Advertisement

Topics

Altan Pharma Announces the Grant of Two Patents by the USPTO Covering its Unique, Intravenous Formulation of Acetaminophen

09:53 EDT 17 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Altan Pharma Limited (“Altan”), an Irish specialty pharmaceutical company, today announced that the United States Patent and Trademark Office (“USPTO”) has granted two patents to Altan covering its intravenous formulatio...

Other Sources for this Article

Altan Media Relations
Mark Gorman
Tel: + 353 1 908 1280
Email: info@altanpharma.com

NEXT ARTICLE

More From BioPortfolio on "Altan Pharma Announces the Grant of Two Patents by the USPTO Covering its Unique, Intravenous Formulation of Acetaminophen"

Advertisement
Quick Search
Advertisement
Advertisement